Dimension

Activity from announced rounds

Activity in this selectionUnited States
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$711M
2 disclosed · full round size, not this investor’s share

By stage

Series C+2

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection
Enveda

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

$311MSeries E
Participant
Chai Discovery

Building AI models to accelerate pre-clinical drug discovery

$400MSeries C
Role not disclosed